A press conference to present BioNanoMed Catalunya, the IBEC-led alliance created to promote nanotechnology applied to healthcare and biotechnology, was held on Friday at the Museu Colet in Barcelona.
The official press launch of BioNanoMed Catalunya, the IBEC-led platform to promote synergies between groups, universities, hospitals and companies doing research in nanotechnology applied to health and biotechnology, featured in the lunchtime news on TV3 on 13 May.
Some of IBEC’s research got some constructive feedback last week with the annual visit of members of the institute’s International Scientific Committee (ISC).
IBEC group leader Ángel Raya is quoted in an article in La Vanguardia about recent research from Harvard that has discovered a cell type previously unknown in the human body.
Postdoc researcher in the Nanobioengineering group Toni Homs was asked to give some feedback to be published on the website of the collaborative project Interbio.
An article entitled “Nanomedicine, the key to early diagnosis” including an interview with IBEC associate director Josep Samitier appears in Diario Medico.
We may be several steps closer to understanding one of the major pathologies that affects sufferers of cystic fibrosis, thanks to Senior researcher Eduard Torrents of IBEC’s Microbial biotechnology and host-pathogen interaction group.In a study published this week in the American Society for Microbiology’s journal Infection and Immunity, Eduard and his collaborator in Stockholm, Britt-Marie Sjöberg, looked at DNA synthesis in Pseudomonas aeruginosa, a bacterial infection that is a frequent complication in many people with cystic fibrosis, and a common cause of death in those patients.
Some recent research by the Biomedical Signal Processing and Interpretation group has been featured in the section ‘Literature Review: A roundup of the most important recent studies’ in ENT Today magazine.
Spanish national TV channel RTVE are paying a visit to IBEC today to interview Ángel Raya, group leader of the Control of Stem Cell Potency group, on the subject of stem cell research for an episode of the science and technology programme ‘Tres14’.